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doi:10.1016/j.jtcvs.2007.04.074bjective: Adverse neurodevelopmental sequelae are common in children with
ongenital heart defects. Tetralogy of Fallot is part of the clinical phenotype of many
enetic syndromes. We evaluated the determinants of neurodevelopmental outcome
n patients with tetralogy of Fallot.
ethods: We performed a subgroup analysis of children with tetralogy of Fallot
ndergoing complete repair before 6 months of age who were enrolled in a trial
ssessing apolipoprotein E genotype as a predictor of neurodevelopmental outcome.
ssessment included genetic evaluation, neurologic examination, and the Bayley
cales of Infant Development-II, yielding the Mental Developmental Index and
sychomotor Developmental Index.
esults: Sixty children were tested at 1 year of age. A confirmed or suspected
enetic syndrome was identified in 18.3%. The mean Mental Developmental Index
as 89 13, and the mean Psychomotor Developmental Index was 81 17. Scores
or the Mental Developmental Index (76  13 vs 92  11) and Psychomotor
evelopmental Index (63  13 vs 85  15) were significantly lower for patients
ith genetic syndromes. The presence of a genetic syndrome was a predictor of
ower Mental Developmental Index and Psychomotor Developmental Index (P 
002 and P  .001). The presence of tetralogy of Fallot with pulmonary atresia and
he apolipoprotein E 2 allele were predictive of a lower Mental Developmental
ndex (P  .001 and P  .035). No other preoperative or operative variables were
redictive of worse neurodevelopmental outcome.
onclusions: At 1 year of age after repair of tetralogy of Fallot, most patients had
eurodevelopmental scores within the normal range. Genetic syndromes and the
polipoprotein E 2 allele were important risk factors for neurodevelopmental
ysfunction and accounted for some interindividual differences in outcome.
etralogy of Fallot (TOF) is one of the most common forms of congenital
heart disease, with a prevalence of 0.026 to 0.048 per 1000 live births.1 In the
current surgical era, complete intracardiac repair for TOF is commonly
erformed during infancy, with actuarial survivals of 95% after 5 years and 86%
fter 30 years.2 Although the long-term mortality rate after TOF repair is low, 
s growing recognition and concern that these patients are at increased risk of
dverse neurodevelopmental (ND) outcomes. Preoperative risk factors, such as
hronic hypoxemia, hypoperfusion, acidosis, and thromboembolic events, have been
dentified as risk factors for adverse ND outcomes in this patient populat3-5
ntraoperative management strategies, including the duration of cardiopulmonary
ypass (CPB), use and duration of deep hypothermic circulatory arrest (DHCA),
emodilution, degree of hypothermia, and blood gas management, have been
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Dmplicated as potential contributors to cerebral injury.6-10
owever, these factors do not fully account for the d
nces in ND outcome observed among individuals w
OF who underwent comparable surgical procedures, s
esting that the pathogenesis of adverse ND outcome
his patient population is multifactorial.
TOF is a phenotypic feature or an associated cli
nding of many genetic syndromes and chromosom
nomalies associated with impaired ND.11 As many as 16%
f patients with TOF have 22q11 microdeletions, Do
yndrome, Alagille’s syndrome, Cat Eye syndrome, 
HARGE and VATER associations.11-15 Overall, patients
ith TOF have been noted to have poorer ND outc
han the healthy population.3,16 DeMaso and associates17
eported that 22% of patients with TOF, most of w
nderwent complete surgical repair, scored less than 80
tandardized intelligence quotient testing, approximate
.5 standard deviations (SDs) less than the expected m
core of 100. Few data are available regarding ND outc
or patients after surgical repair of TOF in infancy wh
onfounding genetic variables are taken into considerati
In addition, genetic polymorphisms exist that may im
euroresiliency and increase susceptibility to neurolog
njury after infant heart surgery. Apolipoprotein E (APOE)
s an important regulator of cholesterol metabolism in
entral nervous system and plays a pivotal role in
obilization and redistribution of cholesterol and phosp
ipids during neuronal remodeling.18,19 Specifically, APOE
2 allele carriers have been shown to have lower scor
he Psychomotor Development Index (PDI) of the Bay
cales of Infant Development-II at 1 year of age 
eonatal and infant cardiac surgery.20
The purpose of this study was to determine the frequ
f abnormal ND outcomes in 1-year-old patients with 
fter surgical repair. In addition, we sought to determin
ole of genetic factors, including APOE polymorphisms
eterminants of poor ND outcomes in this pat
opulation.
aterials and Methods
his study constitutes a post hoc analysis of a prospective o
Abbreviations and Acronyms
APOE apolipoprotein E
CPB  cardiopulmonary bypass
DHCA deep hypothermic circulatory arrest
MDI Mental Developmental Index
ND  neurodevelopmental
PDI  Psychomotor Developmental Index
SD  standard deviation
TOF  tetralogy of Fallotational cohort study assessing the effects of polymorphisms ofa
2 The Journal of Thoracic and Cardiovascular Surgery ● Janua-
s
s
n
r
-
POE on ND outcomes in patients aged 6 months or less 
oing surgical repair for congenital heart disease.20 The institu-
ional review board at The Children’s Hospital of Philadel
pproved the study. Informed consent was obtained from 
arent or guardian.
atient Population
etween October of 1998 and April of 2003, infants with 
TOF/pulmonary stenosis or TOF/pulmonary atresia) undergoi
omplete biventricular repair by the age of 6 months were el
or the study. Infants with TOF/absent pulmonary valve and 
ulmonary atresia with multiple aortopulmonary collaterals w
xcluded. Other exclusion criteria included (1) major recogniz
ongenital defects, (2) recognizable genetic or phenotypic s
rome other than chromosome 22q11 microdeletions, and 
anguage other than English spoken at home.
Operations were performed at a single institution by 4 ca
urgeons with a team of dedicated cardiac anesthesiologists. Al
tat blood gas management was used. DHCA was used at the 
ion of the surgeon. Before DHCA, patients underwent cooling 
opical hypothermia and CPB to a nasopharyngeal temperatur
8°C. Modified ultrafiltration was performed in all patients.
ne-year Neurodevelopmental Examination
he protocol for ND examination has been described.20 In short,
hildren were evaluated at 12 months of age  2 weeks, adjusted
ppropriately for prematurity. Development was assessed by the 
ey Scales of Infant Development-II, which is composed of 2 se
cores. The PDI assesses fine and gross motor skills, and the M
evelopmental Index (MDI) evaluates cognition, language, memo
roblem-solving, and social skills. Both the PDI and MDI yield 
hat are normalized to a mean of 100  15. Therefore, a score of 
r less is greater than 2 SDs below the mean.
In addition, the neurologic evaluation included a medical 
ory, growth measurements, and a complete neurologic exam
ion assessing active and passive tone, reflexes, gross motor s
nd visual and auditory responses by a single developm
ediatrician. The results of the neurologic examination were 
idered “normal” if no abnormalities or only mild abnorma
hat did not affect motor skills were found, “suspect” when there
as a moderate degree of abnormality, and “abnormal” when
ignificant abnormalities of tone, reflexes, or motor skills were
resent. Microcephaly was defined as a head circumference less
han or equal to the 5th percentile for age.
Patients were also evaluated by a genetic dysmorphologist.
iven the difficulty in detecting dysmorphic features and genetic
yndromes in the neonatal period, some children with unrecog-
ized genetic abnormalities had been enrolled as infants. Chromo-
ome analysis and testing for microdeletions of chromosome
2q11 were performed as indicated.
tatistical Analysis
ontinuous data are expressed as mean  SD. Independent t tests
ere used for comparison of continuous variables, and chi-square
nd Fisher exact tests were used for comparison of discrete vari-
bles as appropriate. Regression analysis was used to assess the
ssociation between risk factors and PDI and MDI scores. Initial
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Dnivariate analysis was performed on potential predictors of ND
utcome, including gestational age, ethnicity, socioeconomic sta-
us, birth weight, birth length, birth head circumference, sex,
elivery method (caesarean or vaginal), multiple gestation birth, 1-
nd 5- minute Apgar scores, preoperative intubation and prosta-
landin use, presence of a confirmed or suspected genetic syn-
rome, APOE genotype, age and weight at the time of surgery,
xtracorporeal membrane oxygenation/left ventricular assist de-
ice, delayed sternal closure, hematocrit (first value obtained on
ypass after hemodilution), intraoperative support time (CPB and
ABLE 1. Baseline characteristics* and intraoperative sta
eturn for neurodevelopmental testing
S
aseline characteristics
Male:female, ratio
Race
White
Hispanic
Black
Other
APOE allele group
22 and 23
33
34 and 44
SES 4
Gestational age, wk 3
Birth weight, kg
Head circumference, cm 3
Microcephaly (head circumference  5%), n
Caesarean delivery
Multiple birth
Genetic disorder
Diagnosis of TOF/PA
Apgar 1 8
Apgar 5 8
Delayed sternal closure
ECMO/LVAD
Preoperative prostaglandin, n
perative data
Age at surgery, mo 2
Weight at surgery, kg
Single operative procedure, n
Total support time, min 6
Total CPB time, min 5
Use of DHCA, n
Total DHCA time, min 1
Max DHCA 11
HCT 26
NP_temp 23
POE, Apolipoprotein E; SES, socioeconomic status; TOF/PA, tetralogy of Fa
entricular assist device; CPB, cardiopulmonary bypass; DHCA, deep hyp
Reflects baseline characteristics that were retrospectively analyzed at theHCA), number of operations and episodes of CPB, and use and o
The Journal of Thoracuration of DHCA. With respect to the APOE genotype analysis,
ubjects were grouped into the 2 group (22 and 23), 33
roup, and 4 group (34 and 44). Two patients with 24
ere excluded from the analysis because of the opposing effects of
2 and 4 in Alzheimer disease.
Variables that were marginally significant at P less than .10
ere then included in stepwise multivariable regression analysis to
dentify independent predictors, and the most parsimonious model
as used. Because the presence of a confirmed or suspected
enetic syndrome was such a strong univariate predictor of ND
cs of the study group and enrolled patients who did not
group
Enrolled patients who
did not return P value
60 n  23
29 15:08 .387
.336
5%) 13 (70%)
%) 1 (4%)
2%) 4 (17%)
3%) 2 (9%)
.469
%) 3 (14%)
0%) 15 (68%)
1%) 4 (18)
0.92 No data
3.0 39 1.0 .488
0.7 3.1  0.6 .549
2.3 33.5 1.5 .571
8%) 5 (22%) .967
7%) 13 (57%) .545
%) 0 (0%) .486
8%) 4 (17%) .827
%) 1 (4%) .654
1.44 8.14 0.57 .530
0.55 8.95 0.50 .230
%) 0 (0%) .663
%) 0 (0%) .616
%) 1 (4%) .869
1.4 3.24 1.8 .177
1.53 5.0 1.36 .625
8%) 20 (87%) .111
21 89 34 .076
19.7 83 37 .018
7%) 4 (17%) .153
17.3 6.0 12 .081
17.31 5.61 12.60 .083
4.56 26.70 3.84 .806
4.77 24.48 3.76 .277
ulmonary atresia; ECMO/LVAD, extracorporeal membrane oxygenation/left
ic circulatory arrest; HCT, hematocrit; NP, nasopharyngeal.
ar mark. †Max DHCA refers to the longest, single-time exposure to DHCA.tisti
tudy
n 
31:
45 (7
0 (0
7 (1
8 (1
5 (9
35 (6
18 (3
.22
8.0
3.0
3.0
11 (1
40 (6
4 (7
11 (1
3 (5
.00
.79
3 (5
1 (2
4 (7
.64
4.8
59 (9
8.0
6.3
22 (3
1.7
.70
.45
.38
llot/p
othermutcome, the cohort was divided on the basis of whether a genetic
ic and Cardiovascular Surgery ● Volume 135, Number 1 93
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Dyndrome was detected. Separate multivariable analyses were 
ormed on each of these group’s predictors.
esults
etween October 1, 1998, and March 24, 2003, 111 eligible
atients were diagnosed with TOF and underwent surgery with
PB at the age of 6 months of less. A total of 96 patients (83%)
ere enrolled in the prospective study. Eighty-three patients
86%) underwent complete intracardiac repair and were eligi-
le for this study. The remaining 13 patients underwent a
alliative surgical procedure or had complex anatomy (absent
ulmonary valve, multiple aortopulmonary collaterals) and
hus did not meet inclusion criteria. There was no surgical
ortality in the study group. Of the 83 potential patients, 60
72%) returned for the 1-year evaluation and constitute the
tudy population. The primary reason for not returning was
ack of funds for travel.
The baseline characteristics and intraoperative details are
resented in Table 1. Overall, there was no gender pre
nance in our patient population. Fifty-nine patients (98%)
nderwent a single surgical procedure. One patient required
eoperation before testing at 1 year. DHCA was used in 22
rocedures (37%). Five patients (8%) required multiple
eriods of CPB during the initial repair. There was no
tatistical difference in baseline characteristics between the
tudy group and those enrolled patients who did not return
or ND testing. However, longer CPB, and therefore total
upport, times had been used for those patients who did not
eturn for a 1-year assessment compared with the study
roup.
ND testing was performed, on average, at 12.24  0.6
onths. The mean weight was 8.7  1.2 kg, and the mean c
4 The Journal of Thoracic and Cardiovascular Surgery ● Janua-
ead circumference was 45.7  1.9 cm. Fifteen patients
25%) had microcephaly (5%) at the time of testing, 5 of
hom had been microcephalic at birth. The neuromuscular
xamination results were abnormal in 5 patients (8.3%) and
uspect in 13 patients (21.7%). Varying degrees of hypoto-
ia accounted for all abnormalities in the neuromuscular
xamination.
Neonatal recognition of dysmorphic features may be
ifficult; therefore, some patients were enrolled in whom the
iagnosis of a genetic syndrome was not made until the
-year evaluation. Therefore, although patients with recog-
ized genetic syndromes (eg, trisomy 21), except for 22q11
icrodeletions, were not enrolled, a confirmed or suspected
enetic syndrome was identified at the 1-year evaluation in
8.3% of the patients. Testing for 22q11 microdeletions was
erformed in 57 of 60 patients (95%) and identified in 6
atients. Overall genetic syndromes were identified in 11
atients, including 22q11 (6), CHARGE association (2),
ATER association (1), Holt-Oram (1), and an undiagnosed
yndrome (1). The APOE allele frequencies were 5.8%,
6.7%, and 17.5% for 2, 3, and 4, respectively, as
xpected for a primarily white population. There were no
22 carriers in this study population.
For the entire cohort, the mean MDI was 89 13 and the
ean PDI was 81  17. When the scores were analyzed in
he context of an underlying genetic syndrome (Figure
cores for the MDI were significantly lower for those with
genetic syndrome (76  13) versus those without (92
11). Only 4% (2/49) without an underlying genetic syn-
rome scored below 2 SDs of normal on the MDI, in
Figure 1. Comparison of ND scores for
MDI and PDI between patients with
TOF with a coexisting genetic syn-
drome versus those without at 1 year
of age. Both MDI and PDI are normal-
ized to 100  15. MDI, Mental Devel-
opmental Index; PDI, Psychomotor De-
velopment Index.ontrast with 27.2% (3/11) with a genetic syndrome who
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Dcored below 2 SDs of the norm. Similarly, scores fo
DI were significantly lower for those with a genetic 
rome (63  13) versus those without (85  15) (Figure 2)
ourteen percent of patients (7/49) without a genetic 
rome scored below 2 SDs of normal on the PDI, com
ith 63.6% of patients (7/11) with a genetic syndrome
ote, there was no difference between MDI and PDI s
mong those with a genetic syndrome when specific
omparing those with the 22q11 microdeletion (n  6)
ersus those without (n5).
In the absence of the APOE 2 allele, most 1-year-ol
hildren had normal MDI scores (91  2), with only 7.3%
4/55) scoring below 2 SDs of normal. In contrast, APOE 2
llele carriers had lower MDI scores (78  8) compared with
hose without the 2 allele, of whom 40% (2/5) scored be
 SDs of normal. PDI scores did not vary across APOE
enotypes.
Table 2 shows the univariate regression results for fa
redicting MDI and PDI at a P value less than .10, the cut
YesNo
120
110
100
90
80
70
60
50
M
D
I
YesNo
120
110
100
90
80
70
60
50
P
D
I
Genetic Syndrome
igure 2. In the absence of a genetic syndrome, MDI and PDI
cores for children who underwent surgical repair of TOF are
ithin 1 SD of accepted normal values (100  15). Patients with
OF and a coexisting genetic syndrome have significantly lower
cores for both MDI and PDI compared with those without ge-
etic syndromes. TOF, Tetralogy of Fallot; PDI, Psychomotor De-
elopment Index.sed for inclusion in the multivariate analysis. Table 3 showc
The Journal of Thorae
-
d
f
s
he final models, based on stepwise regression analysis. 
resence of a genetic syndrome was identified as a predic
ower MDI (P  .02) and PDI (P  .001) scores in the fin
odels. In addition, the presence of an APOE 2 allele (P 
02) and diagnosis of TOF with pulmonary atresia (P  .001)
ere predictive of lower MDI scores in the multivariate 
sis. When only subjects with no genetic syndrome 
onsidered, the APOE 4 allele was also associated with
ecreased MDI score. No predictors other than the presen
 genetic syndrome were significantly associated with the 
core in the final models. Birth weight, gestational age, s
conomic status, and age at surgery were not predictiv
dverse ND outcomes. Intraoperative variables, including 
r duration of DHCA, total support time, and surgeon, w
ot significantly associated with lower ND scores in the fin
odels.
iscussion
n the absence of a genetic syndrome, most 1-year-old
ABLE 2. Univariate regression models for Mental Devel-
pmental Index and Psychomotor Developmental Index
Univariate models (N  60)
ariable B SE P value
DI
Diagnosis of TOF/PA 29.965 6.712 .000
Genetic disorder 16.082 3.840 .000
PGE 22.643 6.113 .000
Total_DHCA.surg1 0.280 0.092 .003
DHCA_max 0.280 0.092 .003
DHCA_total 0.276 0.091 .004
NP_temp 0.882 0.340 .012
DHCA.number 7.666 3.106 .017
Weight.surg1 2.367 1.076 .032
Surgeon .063
Operations 16.690 9.188 .074
Bypass 10.618 5.974 .081
APOE.genotype .087
DI
Genetic disorder 21.826 4.849 .000
Diagnosis of TOF/PA 27.088 9.345 .005
PGE 20.607 8.307 .016
Weight.surg1 3.109 1.380 .028
Total_DHCA.surg1 0.258 0.122 .039
DHCA_max 0.258 0.122 .039
DHCA_total 0.253 0.121 .042
Apgar_1 2.729 1.490 .072
NP_temp 0.775 0.450 .090
DI, Mental Developmental Index; SE, standard error; TOF/PA, tetralogy of
allot/pulmonary atresia; PGE, prostaglandin; DHCA, deep hypothermic
irculatory arrest (DHCA_max: single maximal exposure to DHCA); NP,
asopharyngeal; APOE, apolipoprotein E.shildren with TOF scored within 2 SDs of normal on both
cic and Cardiovascular Surgery ● Volume 135, Number 1 95
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Dhe MDI and the PDI of the Bayley Scales of Infant
evelopment-II. In contrast, scores on the MDI and PDI
ere often abnormal in patients with coexisting genetic
yndromes. In one of the largest studies from Boston
hildren’s Hospital of ND outcome in patients who have
equired CPB for repair of congenital heart disease, the
nvestigators found that patients who underwent repair of
OF had poorer ND outcomes in comparison with those
ho underwent an arterial switch operation for transpo-
ition of the great arteries.9 Although their study did n
pecifically target this issue, the investigators hypothe-
ized that the difference between the 2 groups was related
o a known prevalence of genetic syndromes associated
ith TOF. Our data confirm this hypothesis that patients
ith TOF and a coexisting genetic syndrome have a
reater likelihood of adverse ND outcome after complete
ntracardiac repair.
Despite the intended exclusion of patients with recog-
izable genetic or phenotypic syndromes other than chro-
osome 22q11 microdeletions, 18.3% of our study pa-
ients were subsequently found to have a genetic
yndrome, underscoring the prevalence of genetic abnor-
alities in patients with TOF. The most common genetic
isorder was 22q11 microdeletion, consistent with re-
orts citing up to a 16% incidence of 22q11 microdele-
ion in patients with TOF.12 In a psychoeducational pro-
le performed by Moss and associates,21 patients with
2q11 microdeletions had significant weakness in visual-
ABLE 3. Multivariate regression models for Mental De-
elopmental Index and Psychomotor Developmental Index
ultivariate models
ariable B CI (97.5) CI (2.5) SE P
ll subjects (N  60)
MDI
Diagnosis of TOF/PA 27.897 15.234 40.560 6.313 .000
Genetic disorder 8.791 1.535 16.047 3.618 .019
APOE.2 12.908 3.135 22.681 4.873 .011
PDI
Genetic disorder 22.559 13.148 31.970 4.698 .000
enetic syndromes
excluded (N  49)
MDI
Diagnosis of TOF/PA 41.200 22.715 59.685 9.166 .000
APOE.2 11.867 0.855 22.878 5.460 .035
APOE.4 6.892 0.854 12.931 2.994 .026
PDI
No significant
variables
I, Confidence interval; SE, standard error; MDI, Mental Developmental
ndex; TOF/PA, tetralogy of Fallot/pulmonary atresia; APOE, apolipoprotein
; PDI, Psychomotor Developmental Index.patial perception, problem-solving, nonverbal reason- s
6 The Journal of Thoracic and Cardiovascular Surgery ● Januang, and impaired novel reasoning and concept formation,
espite receiving special education for those areas. These
esults reflect more recent findings by Gerdes and co-
orkers22 and Maharasingam and coworkers,23 who in-
ependently demonstrated profound delays in speech and
anguage development in patients with 22q11 microdele-
ions that were independent of underlying cardiac disease
r need for cardiac surgery.
In addition, genetic polymorphisms may influence a per-
on’s ability to recover from a neurologic insult. Specifi-
ally, APOE is the primary lipid transporter in the central
ervous system. Its primary function is maintenance of cell
embrane integrity in the neuronal cytoskeleton. APOE
ynthesis is up-regulated in response to neuronal injury and
lays a crucial role in neuronal repair.18 There are 3 com-
on isoforms of APOE, which are encoded by 3 alleles: 2,
3, and 4. In adults, the 4 allele has been implicated as a
isk factor for outcomes after central nervous system isch-
mia, traumatic brain injury, and cardiac surgery.24,25 More
ecently, Gaynor and associates20 found the APOE 2 allele
redicts worse ND outcome at 1 year of age after infant
epair of congenital heart defects. The current study ad-
resses the subset of patients with TOF from that larger
tudy. In the current study, APOE 2 and 4 allele carriers
ad significantly lower MDI scores, implicating APOE ge-
otype as a predictor in ND dysfunction after infant cardiac
urgery for TOF.
Over the years, attention has been focused on the use
f CPB during infancy as a cause of poor ND outcome. In
his study, abnormal MDI and PDI scores were not re-
ated to intraoperative variables. Specifically, the age at
he time of surgery, the use or duration of DHCA, and the
otal support time were not associated with worse scores.
lthough the neurologic sequelae of CPB have been
xtensively studied in adults, their impact on childhood
eurodevelopment remains controversial. Prolonged du-
ation of DHCA has been implicated by many as a
ignificant risk factor for worse ND outcome, observing
hat risk increases when the duration of DHCA exceeds
5 to 50 minutes.7,9,10,26,27 In our study, the mean du-
ion of DHCA was 30.7 minutes and neither the use nor
he duration of DHCA was a risk factor for adverse ND
utcome. This is similar to the findings published by
altman and associates,28 in which the duration 
HCA was not a risk factor for poor neurologic outcome
fter infant surgical closure of ventricular septal defects.
he current study and others support the hypothesis that
atient-specific factors are important determinants of
D outcomes after neonatal and infant cardiac surgery
nd contribute more substantially to the risk of adverse
D outcomes than do intraoperative managementtrategies.29
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CH
Dimitations
his study represents a post hoc analysis of a subset of patients
rom a larger cohort of subjects enrolled in a study designed to
valuate the association between APOE genotype polymor-
hisms and postoperative ND outcome. Thus, this study was
ot specifically powered to address the risk factors for adverse
D outcome in patients with TOF. Second, those patients who
ere enrolled in the study but did not return for ND assessment
t 1 year did require longer CPB and, therefore, total support
imes. Third, although the finding of TOF/pulmonary atresia
as a risk factor for adverse ND outcome, the small number of
atients with this entity (n  3) precluded any meaningful
urther speculation or analysis. Finally, this study is limited to
he ND outcome at the 1-year benchmark. It is possible that
urther developmental concerns and abnormalities will be un-
overed when this cohort of patient is followed over time.
onclusions
t 1 year of age, most patients who underwent repair of
OF had normal ND scores. Intraoperative management
trategies were not predictive of ND outcomes. The pres-
nce of a genetic syndrome was associated with ND delay,
hich likely is part of the clinical phenotype. In addition,
he APOE genotype predicted adverse neurologic sequelae,
uggesting that ND outcome is also influenced by factors
hat modulate neurologic resiliency after surgical repair of
OF. Genetic factors may explain interindividual variation
n outcome and must be considered when evaluating ND
utcome in patients with TOF.
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